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TCT-122
Electrode irrigation alters RF ablation treatment zone geometry and preserves
medial and adventitial tissue while maintaining injury to renal nerves
John Keating1, Peter Markham2, James Stanley1, Abraham R. Tzafriri2, Gee Wong1,
Anna Spognardi1, Kristine Fuimaono3, Debby Grunewald3, Patrick O'Fallon3,
Elazer Edelman4
1CBSET, Inc., Lexington, MA, 2CBSET Inc., Lexington, MA, 3Cordis/Biosense
Webster, Inc. a Johnson & Johnson Company, Irwindale, CA, 4Harvard-MIT
Biomedical Engineering Center, Cambridge, Massachusetts
Background: We quantitatively compared lesion geometry and artery and nerve
injury with and without irrigation during RF ablation to enable optimization of
catheter design and understanding of temperature gradients.
Methods: RF ablations, using spatially discrete electrodes, were conducted in swine
using THERMOCOOL irrigated tip catheter (Biosense Webster, CA) with and
without irrigation. Arteries were harvested at 7d and serial sectioned every 300 mm
and quantiﬁed histomorphometrically (Fig 1).Results: Surface irrigation lowered affected luminal circumference (irrigated 6.1% vs.
non-irrigated 44.6%); media (irrigated 11.7% vs. non-irrigated 35.4%); and EEL
circumference (irrigated 18.9% vs. non-irrigated 45.4%). RF ablation effects in the
nerve-rich adventitia were less sensitive to irrigation: width (irrigated 3.8mm vs. non-
irrigated 4.8mm) and depth (irrigated 5.1mm vs. non-irrigated 3.4mm). Morphologic
nerve changes within the ablation zones were comparable with and without irrigation
and were considered to be marked and necrotic/degenerative.
Conclusions: Irrigation preserved arterial integrity and reduced linear, circumferential,
and radial injury at the luminal surface and within media and adventitia while providing
comparable nerve injury. These data were used to develop a computational model of RF
energy delivery and injury for further optimization of irrigation and powering protocols.
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Preliminary safety and efﬁcacy results from the REALISE trial: REnAL
denervatIon by ultraSound transcatheter Emission
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Background: Catheter-based renal denervation has emerged as a method for treating
the overactivity of the sympathetic nervous system. The PARADISE system (ReCor
Medical, Menlo Park, CA) is a unique therapeutic non-focused ultrasound system
designed to perform circumferential renal denervation while preventing damage to the
renal artery. The purpose of the REALISE trial is to evaluate the safety and efﬁcacy of
the PARADISE system in patients suffering from resistant hypertension.
Methods: The REALISE trial is a 20-patient prospective study conducted by multi-
disciplinary teams at two sites in France (Hôpital Pitié-Salpêtrière, Paris; Hôpital
Rangueil, Toulouse). Patients suffering from resistant hypertension as deﬁned by the
ESH-ESC guidelines (ofﬁce blood pressure above 140/90 mmHg with a minimum of
3 antihypertensive drugs including a diuretic) were screened and eligibility further
conﬁrmed by home and/or ambulatory measurements. Renal denervation was per-
formed bilaterally with the PARADISE system, delivering 2 to 3 ultrasound emissionsB40 JACC Vol 62/18/Suppl B j October 27 November 1, 2013 jin each artery. All patients underwent CT-scan or MRI at baseline and follow-up to
assess the renal arteries.
Results: Preliminary results indicated that 63% of enrolled and treated patients were
under spironolactone therapy. Bilateral denervation was performed by delivering an
average of 5.7 ultrasound emissions in each subject (average heating time 3.3 minutes
per subject). Sedatives and analgesics were administered during the intervention and
the treatment was well tolerated by all patients. Preliminary results at 6 months were
comparable to published data on radiofrequency renal denervation with an average
reduction in ofﬁce and ambulatory blood pressure of -21/-9 mmHg and 9/ 4 mmHg,
respectively. Systematic imaging of the renal arteries showed no arterial stenosis or
arterial damage at follow-up.
Conclusions: Endovascular ultrasound renal denervation appears to be a safe and
effective treatment for resistant hypertension. Results on all 20 patients from the
REALISE study will be presented at the conference.
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A novel appliance for transcatheter mitral cerclage annuloplasty
June-Hong Kim1, Si Chan Sung1, Jongha Park1, Jeong Heo2, Yong-Hyun Park1,
Jin-Pyong Kim3, Jun-Ho Kim1, Robert J. Lederman4
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Background: Mitral cerclage annuloplasty is a transcatheter coronary sinus annulo-
plasty that establishes circumferential tension around the mitral annulus by traversing
the basal interventricular septum between the great cardiac vein and the right
ventricular outﬂow tract. We have developed a novel implant to effect annuloplasty
while preventing myocardial erosion; avoiding compression of coronary arteries,
tricuspid leaﬂet, AV node; and displaceing the knot ﬁxation to a safe caval location.
Methods: The cerclage appliance is positioned over a 0.018" nylon-coated ﬂexible
and radiopaque stainless steel braidwire. It consists of conjoined semirigid coronary
sinus and trans-tricuspid limbs (CS, TV, Figure) and is used along with a coronary
artery protection arch. X-ray guided cerclage was performed in swine (n¼6,
55w80kg) to investigate the device performance.
Results: The cerclage appliance was easily delivered over the cerclage suture and
assumed its intended anatomic position along the coronary sinus and across the
tricuspid valve. Tension accomplished circumferential mitral annular reduction while
the TV limb protected the TV and AV node from direct contact. Neither conduction
block nor TV malfunction was observed after two-week survival (n¼1).
Conclusions: This novel cerclage appliance addresses potential shortcomings of
transcatheter cerclage annuloplasty in a simple-to-deploy device.TCT-125
Novel Thoracoscopically Assisted Trans-Catheter Ventricular Restoration
Therapy: Feasibility and Efﬁcacy in an Anteroseptal Aneurysmal Ovine Model
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Greg L. Kaluza1, Juan Granada1
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Background: Surgical ventricular reconstruction has been used as heart failure
treatment in patients with large ventricular aneurysms. Based on a well-established
device-based (BioVentrix, San Ramon, CA) surgical technique operation, this study
assessed the feasibility of performing minimally invasive thoracoscopically assisted
transcatheter ventricular restoration (TCVR) in an anteroseptal ovine infarction model.
Methods: Ventricular aneurysmal model development was achieved by coil-occlusion
of the left anterior descending artery. 8 weeks after occlusion, TCVR was performed
in ﬁve sheep via a 4 cm left thoracotomy. Under endoscopic and ﬂuoroscopic guid-
ance, LV scar was visualized and trans-epicardial puncture was performed advancing
a guidewire at the lateral margin of the scar, across a portion of the LV, and through
the interventricular septum into the right ventricle. With one end still protruding from
the left chest, the guidewire was retrieved with a snare via the right external jugular
vein through a percutaneous approach. Then an inner anchor on a tether was inserted
over the wire and positioned on the right side of the interventricular septum. The
opposite end of the tether protruded through LV anterolateral wall and an outer
locking anchor was deployed over the tether on the LV anterior epicardium. Serial
pairs of anchors were then approximated to exclude the intervening portion of theTCT Abstracts/ORAL/First-in-Human Studies: Global Regulatory and Translational Considerations
